Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
The first construction phase of the Hovione Tejo Campus in Seixal has entered its final stage, with commissioning set for mid-2027. Spanning 42 hectares to support future expansions, the site will initially feature two production buildings, one for particle engineering technologies and one for final dosage forms. Facilities will be equipped with cutting-edge automation. With an initial investment of around €200 million, the project will create around one hundred highly skilled jobs, enabling Hovione to expand its industrial capacity and reinforce its global position.
With the opening of this new Campus, Hovione will operate five manufacturing sites across three continents: two in Portugal (Loures and Seixal), and one each in Ireland (Cork), the United States (New Jersey), and Macau.
The first construction phase of the Hovione Tejo Campus in Seixal has entered its final stage, with commissioning set for mid-2027. Spanning 42 hectares to support future expansions, the site will initially feature two production buildings, one for particle engineering technologies and one for final dosage forms. Facilities will be equipped with cutting-edge automation. With an initial investment of around €200 million, the project will create around one hundred highly skilled jobs, enabling Hovione to expand its industrial capacity and reinforce its global position.
With the opening of this new Campus, Hovione will operate five manufacturing sites across three continents: two in Portugal (Loures and Seixal), and one each in Ireland (Cork), the United States (New Jersey), and Macau.
